Literature DB >> 19022160

Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease.

Tomasz J Guzik1, Wei Chen, Maria C Gongora, Bartlomiej Guzik, Heinrich E Lob, Deepa Mangalat, Nyssa Hoch, Sergey Dikalov, Pawel Rudzinski, Boguslaw Kapelak, Jerzy Sadowski, David G Harrison.   

Abstract

OBJECTIVES: This study sought to examine the expression and activity of the calcium-dependent nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) in human atherosclerotic coronary arteries.
BACKGROUND: The NOX-based NADPH oxidases are major sources of reactive oxygen species (ROS) in human vessels. Several NOX homologues have been identified, but their relative contribution to vascular ROS production in coronary artery disease (CAD) is unclear; NOX5 is a unique homolog in that it is calcium dependent and thus could be activated by vasoconstrictor hormones. Its presence has not yet been studied in human vessels.
METHODS: Coronary arteries from patients undergoing cardiac transplantation with CAD or without CAD were studied; NOX5 was quantified and visualized using Western blotting, immunofluorescence, and quantitative real-time polymerase chain reaction. Calcium-dependent NADPH oxidase activity, corresponding greatly to NOX5 activity, was measured by electron paramagnetic resonance.
RESULTS: Both Western blotting and quantitative real-time polymerase chain reaction indicated a marked increase in NOX5 protein and messenger ribonucleic acid (mRNA) in CAD versus non-CAD vessels. Calcium-dependent NADPH-driven production of ROS in vascular membranes, reflecting NOX5 activity, was increased 7-fold in CAD and correlated significantly with NOX5 mRNA levels among subjects. Immunofluorescence showed that NOX5 was expressed in the endothelium in the early lesions and in vascular smooth muscle cells in the advanced coronary lesions.
CONCLUSIONS: These studies identify NOX5 as a novel, calcium-dependent source of ROS in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022160      PMCID: PMC2593790          DOI: 10.1016/j.jacc.2008.07.063

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

Review 1.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Nitric oxide is a physiological substrate for mammalian peroxidases.

Authors:  H M Abu-Soud; S L Hazen
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

3.  NOX5 variants are functionally active in endothelial cells.

Authors:  Rachida S BelAiba; Talija Djordjevic; Andreas Petry; Kerstin Diemer; Steve Bonello; Botond Banfi; John Hess; Alexej Pogrebniak; Christian Bickel; Agnes Görlach
Journal:  Free Radic Biol Med       Date:  2006-11-03       Impact factor: 7.376

4.  Coronary artery superoxide production and nox isoform expression in human coronary artery disease.

Authors:  Tomasz J Guzik; Jerzy Sadowski; Bartlomiej Guzik; Andrew Jopek; Boguslaw Kapelak; Piotr Przybylowski; Karol Wierzbicki; Ryszard Korbut; David G Harrison; Keith M Channon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-17       Impact factor: 8.311

5.  Superoxide production and expression of nox family proteins in human atherosclerosis.

Authors:  Dan Sorescu; Daiana Weiss; Bernard Lassègue; Roza E Clempus; Katalin Szöcs; George P Sorescu; Liisa Valppu; Mark T Quinn; J David Lambeth; J David Vega; W Robert Taylor; Kathy K Griendling
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

6.  A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes.

Authors:  B Bánfi; G Molnár; A Maturana; K Steger; B Hegedûs; N Demaurex; K H Krause
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

Review 7.  Vascular NADPH oxidases as drug targets for novel antioxidant strategies.

Authors:  Tomasz J Guzik; David G Harrison
Journal:  Drug Discov Today       Date:  2006-06       Impact factor: 7.851

8.  Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation.

Authors:  Davin Jagnandan; Jarrod E Church; Botond Banfi; Dennis J Stuehr; Mario B Marrero; David J R Fulton
Journal:  J Biol Chem       Date:  2006-12-12       Impact factor: 5.157

9.  Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction.

Authors:  Abdulrahman K Doughan; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2007-12-20       Impact factor: 17.367

10.  Nox regulation of smooth muscle contraction.

Authors:  Darren R Ritsick; William A Edens; Victoria Finnerty; J David Lambeth
Journal:  Free Radic Biol Med       Date:  2007-03-12       Impact factor: 7.376

View more
  119 in total

Review 1.  The Nox family of NADPH oxidases: friend or foe of the vascular system?

Authors:  Ina Takac; Katrin Schröder; Ralf P Brandes
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 2.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

Review 3.  Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.

Authors:  Jennifer Rivera; Christopher G Sobey; Anna K Walduck; Grant R Drummond
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 4.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

Review 5.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

6.  Epithelial nitration by a peroxidase/NOX5 system mediates mosquito antiplasmodial immunity.

Authors:  Giselle de Almeida Oliveira; Joshua Lieberman; Carolina Barillas-Mury
Journal:  Science       Date:  2012-01-26       Impact factor: 47.728

7.  Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.

Authors:  Augusto C Montezano; Dylan Burger; Tamara M Paravicini; Andreia Z Chignalia; Hiba Yusuf; Mahmoud Almasri; Ying He; Glaucia E Callera; Gang He; Karl-Heinz Krause; David Lambeth; Mark T Quinn; Rhian M Touyz
Journal:  Circ Res       Date:  2010-03-25       Impact factor: 17.367

Review 8.  Nox5 and the regulation of cellular function.

Authors:  David J R Fulton
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

Review 9.  NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury.

Authors:  Pamela W M Kleikers; K Wingler; J J R Hermans; I Diebold; S Altenhöfer; K A Radermacher; B Janssen; A Görlach; H H H W Schmidt
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

Review 10.  Role of mitochondrial oxidative stress in hypertension.

Authors:  Sergey I Dikalov; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.